Skip to main content
. 2024 May 8;23(1):e0143. doi: 10.1097/CLD.0000000000000143

TABLE 2.

Who to screen for HBV12

People who…
…were born in countries with a high (≥2% HbsAg-positive) prevalence of HBV infection
…were not previously vaccinated and have parents born in regions with high (≥8%) prevalence of HBsAg
…have behaviors that increase the risk of HBV exposure (eg, high-risk sex or injection drug use)
…have household or sexual contact with someone who is HBsAg-positive or at increased risk of HBV infection
…are undergoing HCV treatment with DAAs
…have abnormal liver function tests of unknown etiology
…are immunosuppressed including patients who have HIV, are on dialysis, are status post organ transplantation, and are receiving chemotherapy and immunosuppressive therapy
…are at least 18 years of age (CDC only)

Abbreviations: CDC, Centers for Disease Control and Prevention; DAA, direct-acting antiviral.